Skip to main content

Research Repository

Advanced Search

Chain length impact on the retro Diels-Alder mediated release of gemcitabine from hybrid nanoparticles towards pancreatic cancer therapy.

Oluwasanmi, Adeolu; Lindsay, Sarah; Curtis, Anthony; Perrie, Yvonne; Hoskins, Clare

Authors

Adeolu Oluwasanmi

Sarah Lindsay

Yvonne Perrie

Clare Hoskins



Abstract

Previously reported gold coated iron oxide nanoparticles (Au-IONP's) have demonstrated their effectiveness as drug delivery vehicles for gemcitabine conjugated to a thermally labile Diels-Alder linker containing a chain of 4 carbon atoms (TTLD4) for the treatment of pancreatic cancer. Heat generated via laser irradiation of Au-IONPs facilitated retro Diels-Alder mediated release in a burst release profile where approximately half of all total release over 180 min occurred within the first 5 min. Two analogues of TTLD4, which differ only in linker chain length (TTLD3 & TTLD6) were synthesised and conjugated to Au-IONP's. Heat-mediated release of gemcitabine at 45 °C over 180 min from these formulations was confirmed to be based on linker length, which was 94%, 76% and 45% for TTLD3, TTLD4 and TTLD6, respectively. Drug loading of the Diels-Alder linkers in a 5:1 Drug/Au-IONP w/w ratio appears to favour those containing an even number of carbons TTLD4 (76%) & TTLD6 (57%) over TTLD3 (25%), possibly due to the linker likely being positioned perpendicular to the Au-IONP surface because of the 120 °C-C bond. [Abstract copyright: Copyright © 2023 The Authors. Published by Elsevier B.V. All rights reserved.]

Citation

Oluwasanmi, A., Lindsay, S., Curtis, A., Perrie, Y., & Hoskins, C. (2023). Chain length impact on the retro Diels-Alder mediated release of gemcitabine from hybrid nanoparticles towards pancreatic cancer therapy. International Journal of Pharmaceutics, 644, Article 123304. https://doi.org/10.1016/j.ijpharm.2023.123304

Journal Article Type Article
Acceptance Date Aug 9, 2023
Online Publication Date Aug 10, 2023
Publication Date Sep 25, 2023
Deposit Date Sep 7, 2023
Journal International journal of pharmaceutics
Print ISSN 0378-5173
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 644
Article Number 123304
DOI https://doi.org/10.1016/j.ijpharm.2023.123304
Keywords Gemcitabine, Retro Diels-Alder, Pancreatic cancer, Hybrid nanoparticle, Thermo responsive drug delivery